OrthoPediatrics Corp. reported $253M of revenue over the trailing twelve months, +14% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $253M (to Q2 2026). Net income: −$40M, trailing twelve months to Q2 2026. Free cash flow: −$1.8M, trailing twelve months to Q2 2026. Operating margin: −12%, trailing twelve months to Q2 2026.

KIDSOrthoPediatrics Corp.

Healthcare

$21.77+20% 1Y

$21.77

$14.6452 weeks$26.52

KIDS as reported

OrthoPediatrics Corp. reported $253M of revenue over the trailing twelve months, +14% on the year before. 10 reported series are charted on this page, each one as filed.

$253M

Revenue, trailing twelve months · to Q2 2026 · +14% against the twelve months before

Net income: −$40M
Net income · −4.9% year on year · trailing twelve months to Q2 2026
Free cash flow: −$1.8M
Free cash flow · −95% year on year · trailing twelve months to Q2 2026
Operating margin: −12%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for KIDS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$253M	+14%	Q2 2026
Net income	−$40M	−4.9%	Q2 2026
EPS	−$1.68	−6.7%	Q2 2026
Gross margin	74%	n/a	Q2 2026
Operating margin	−12%	n/a	Q2 2026
Net margin	−16%	n/a	Q2 2026
ROE	−12%	n/a	Q2 2026
ROA	−8.2%	n/a	Q2 2026
ROIC	−7.6%	n/a	Q2 2026
Free cash flow	−$1.8M	−95%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.